Literature DB >> 3022551

Trace elements and rheumatoid arthritis (RA)--pathogenetic and therapeutic aspects.

E Munthe, J Aaseth, E Jellum.   

Abstract

Rheumatoid arthritis is characterized by increased activity of macrophages which produce toxic forms of oxygen. Such oxygen has been suggested as mediator also of rheumatoid inflammation. Gold accumulates in lysosomes of the macrophages and stabilizes lysosomal and other cell membranes leading to reduced liberation of toxic oxygen. Intracellular production of metallothionein can be induced. Zinc in high doses parenterally can immobilize macrophages and also induce metallothionein-like proteins. Copper and zinc are components of SOD which detoxifies oxygen, and copper-thiolate complexes are reported to be anti-inflammatory. The therapeutic effect of penicillamine and other thiols like aurothiomalate may also be related to an anti-oxidative action. Therapeutic induction of increased intracellular levels of glutathione or administration of selenium in such a form that it incorporates into glutathione-peroxidase and increases the efficacy of the enzyme may lead to accelerated metabolism of toxic oxygen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022551     DOI: 10.1111/j.1600-0773.1986.tb02781.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  3 in total

1.  Plasma selenium levels in rheumatoid arthritis.

Authors:  K Köse; P Doğan; Y Kardas; R Saraymen
Journal:  Biol Trace Elem Res       Date:  1996       Impact factor: 3.738

2.  Metallothionein induction by nonsteroidal antiinflammatory drugs.

Authors:  K H Summer; D Klein; N de Ruiter; J Abel
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

Review 3.  Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments.

Authors:  Viviana Mouriño; Juan Pablo Cattalini; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2011-12-07       Impact factor: 4.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.